1. Okamoto S, Hijikata A. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. the importance of stereostructure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun 1981; 101: 440–7.
2. Sugawara H, Kumon K, Tanaka K, Egou Y, Naitou T, Fujita T. Evaluation of a synthetic inhibitor MD805 as anticoagulant after open heart and vascular surgery. Kyobugeka 1983; 36: 533–37.
3. Fujii H, Kurasako N, Takebayashi T, Tanaka T, Sakano S, Kosogabe Y, et al. Argatroban, a selective thrombin inhibitor for anticoagulant therapy during and following vascular surgery. Masui 1996; 45: 1289–92.
4. Endo S, Kawada T, Mieda T, Hozon M, Abe T, Kikuchi T, et al. A clinical study of an antithrombin agent, argatroban for the prevention of platelet loss in left heart bypass with the Bio-medicus centrifugal pump. Jpn J Artif Organs 1995; 24: 513–6.
5. Cartier R, Blain R. Off-pump revascularization of the circumflex artery: technical aspect and short-term results. Ann Thorac Surg 1999; 68: 94–9.